Not a drug, food additive, or cosmetic
(PubMed) Bianchini F, Vainio H
In contrast, short-acting formulations such as exenatide and the older-generation agent lixisenatide are now prescribed far less frequently, and several formulations have been withdrawn from the market in certain countries, largely due to limited clinical uptake, the availability of more effective long-acting alternatives, and commercial considerations rather than confirmed safety concerns
If you go the telehealth route, make sure the platform requires lab work (at minimum A1C and metabolic panel) before prescribing, and that the prescriber is licensed in your state
[3] Theophylline is arguably the most problematic metabolite, with a 7.2-hour half-life
Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome